See also this year's filing and all EDGAR filings for this company.
PDF Report 0001322505_2014_Albireo_Pharma_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001322505, Albireo Pharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 40,077,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 43,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,031,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 2,441,000 |
| 5 | LiabilitiesNoncurrent | 26,000 |
| 6 | remainder_Liabilities | 6,121,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,843,000 |
| 9 | ResearchAndDevelopmentExpense | 14,296,000 |
| 10 | remainder_Expenses | -453,000 |
| 11 | remainder_Revenues | 56,000 |
| 12 | remainder_NetIncome | 590,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 41,151,000 |
| 1 | Liabilities | 8,588,000 |
| 2 | Expenses | 20,686,000 |
| 3 | Revenues | 56,000 |
| 4 | StockholdersEquity | 32,563,000 |
| 5 | NetIncome | -20,040,000 |
| 6 | ComprehensiveNetIncome | -20,040,000 |
| 7 | BaseVar | 35,535,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.05 |
| 9 | EconomicCapitalRatio | 3.06 |